Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus.
about
The Potential Role of Contraction-Induced Myokines in the Regulation of Metabolic Function for the Prevention and Treatment of Type 2 Diabetes.Nutritionally-induced catch-up growthFish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma.Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.Alterations in vitamin A/retinoic acid homeostasis in diet-induced obesity and insulin resistance.Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.The role of FGF21 in type 1 diabetes and its complications.
P2860
Q33621911-46A74BC8-1D98-45A0-A016-3D8A6ACA97BDQ35003838-A8ECBD79-5BA8-428B-AA57-105C6BED389CQ35726506-4E88E70A-DB84-466C-BD36-FD6ED4FD176DQ37657788-C58BC7C4-7B00-4A88-B27B-B8128279DC10Q37678960-C9488BCE-3F75-4FA3-9085-78309839BC94Q38058339-7A727A78-1C6F-4C3F-BBE1-AD94C790B58FQ38201778-FCB475B4-5563-4AFD-A04A-BAE6BAA55D7AQ38794405-BA8F541B-9E63-4F2F-BCC0-F1A893D1C69EQ39399025-21DB922B-42D5-423D-B233-DD0A6F0AFE41Q44291981-361CC2B6-F7DB-4A6E-9E93-7F8995B21479Q55513236-D79A43BE-58C7-4C99-8ED3-B6131FCA8241
P2860
Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@ast
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@en
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@nl
type
label
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@ast
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@en
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@nl
prefLabel
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@ast
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@en
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@nl
P2093
P2860
P1433
P1476
Effects of short-term continuo ...... osed type 2 diabetes mellitus.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0026359
P407
P50
P577
2011-10-26T00:00:00Z